3 Nasdaq Biotechs With New 52-Week Highs
Biotech stocks are having a bad year with the XBI trending downward for months now, but at least 3 Nasdaq-traded biotechnology companies are now hitting 52-week highs:...
Tags : XBI Ionis Pharmaceuticals Vertex Pharmaceuticals medicines diseases biotech nasdaq diabetes cystic fibrosis
Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Money Nations does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.